Trial Profile
A Retrospective, Real World Study Investigating the Efficacy and Safety of Teduglutide in Patients with Short Bowel Syndrome (SBS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2018
Price :
$35
*
At a glance
- Drugs Teduglutide (Primary)
- Indications Short bowel syndrome
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2018 New trial record
- 10 Oct 2018 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2018.